Pay in 4 interest-free payments of $5.05 Learn more
Ships within 48 hours Β· Estimated delivery Oct 19 - Oct 24
In the future, manufacturers need to continuously monitor regulatory developments and market demands to promote their research and development as well as industrialization processes
however, administration is inadvisable in any patient with a known hypersensitivity to levocarnitine or formulation components
H., & Syed, A
Patients considering these treatments should understand the evidence base, safety considerations, and appropriate clinical indications before proceeding
The molecule is small, cheap to synthesise, and would be difficult to defend commercially
US$ 20.96
US$ 22.16
US$ 29.25
US$ 28.91
